1R5I image
Deposition Date 2003-10-10
Release Date 2004-03-16
Last Version Date 2024-10-30
Entry Detail
PDB ID:
1R5I
Keywords:
Title:
Crystal structure of the MAM-MHC complex
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Mycoplasma arthritidis (Taxon ID: 2111)
(Taxon ID: )
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.60 Å
R-Value Free:
0.24
R-Value Work:
0.23
R-Value Observed:
0.23
Space Group:
I 2 2 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:HLA class II histocompatibility antigen, DR alpha chain
Gene (Uniprot):HLA-DRA
Chain IDs:A, E
Chain Length:181
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:HLA class II histocompatibility antigen, DRB1-1 beta chain
Chain IDs:B, F
Chain Length:190
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Hemagglutinin peptide
Gene (Uniprot):HA
Chain IDs:C, G
Chain Length:13
Number of Molecules:2
Biological Source:
Polymer Type:polypeptide(L)
Molecule:superantigen
Chain IDs:D, H
Chain Length:216
Number of Molecules:2
Biological Source:Mycoplasma arthritidis
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
MSE A MET SELENOMETHIONINE
Ligand Molecules
Primary Citation
Crystal structure of Mycoplasma arthritidis mitogen complexed with HLA-DR1 reveals a novel superantigen fold and a dimerized superantigen-MHC complex.
Structure 12 277 288 (2004)
PMID: 14962388 DOI: 10.1016/S0969-2126(04)00020-6

Abstact

Mycoplasma arthritidis-derived mitogen (MAM) is a superantigen that can activate large fractions of T cells bearing particular TCR Vbeta elements. Here we report the crystal structure of MAM complexed with a major histocompatibility complex (MHC) antigen, HLA-DR1, loaded with haemagglutinin peptide 306-318 (HA). The structure reveals that MAM has a novel fold composed of two alpha-helical domains. This fold is entirely different from that of the pyrogenic superantigens, consisting of a beta-grasped motif and a beta barrel. In the complex, the N-terminal domain of MAM binds orthogonally to the MHC alpha1 domain and the bound HA peptide, and to a lesser extent to the MHC beta1 domain. Two MAM molecules form an asymmetric dimer and cross-link two MHC antigens to form a plausible, dimerized MAM-MHC complex. These data provide the first crystallographic evidence that superantigens can dimerize MHC molecules. Based on our structure, a model of the TCR2MAM2MHC2 complex is proposed.

Legend

Protein

Chemical

Disease

Primary Citation of related structures